Are we ready for universal influenza vaccination in paediatrics?
D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D005191:Family Characteristics; D006760:Hospitalization; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology; D007251:Influenza, Human / Q000150:complications / Q000276:immunology / Q000517:prevention & control*; D009975:Orthomyxoviridae / Q000276:immunology; D010033:Otitis Media / Q000209:etiology / Q000517:prevention & control; D010372:Pediatrics; D012307:Risk Factors; D012959:Socioeconomic Factors; D014611:Vaccination / Q000191:economics / Q000706:statistics & numerical data; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D014613:Vaccines, Attenuated